Thingking of the Administration of Standardization Technical Committee of Medical Device

Chinese Journal of Pharmacovigilance ›› 2010, Vol. 7 ›› Issue (4): 211-212.

Previous Articles Next Articles

Thingking of the Administration of Standardization Technical Committee of Medical Device

DONG Fang

Center for Drug Reevalution, SFDA, Beijing 100045, China

Received:2016-02-19 Revised:2016-02-19 Online:2010-04-08 Published:2016-02-19

Abstract

Abstract: This essay aims to orient the obligations of Standardization Technical Committee of Medical Device(STCMD), study the scientific management which can make the best used of its capability and control medical device.Through combine the practice with the internal characters of medical device, discuss the Methods and measures which manage the technical committee for standardization of medical device and provide guidance and reference for it.

Key words: medical device, Standardization Technical Committee of Medical Device(STCMD), obligation, management

CLC Number:

R955

DONG Fang. Thingking of the Administration of Standardization Technical Committee of Medical Device[J]. Chinese Journal of Pharmacovigilance, 2010, 7(4): 211-212.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/

https://zgywjj.magtechjournal.com/EN/Y2010/V7/I4/211

[1]	LI Dong, SONG Yana, WANG Ligang, BIAN Rongrong, ZHAO Yan. Considerations for Establishing National Sentinel Hospitals for Medical Device Adverse Event Monitoring [J]. Chinese Journal of Pharmacovigilance, 2025, 22(7): 780-785.
[2]	LI Dong, ZHAO Yan. Roles of National Arthroplasty Registries in Post-Market Surveillance of Medical Devices [J]. Chinese Journal of Pharmacovigilance, 2025, 22(6): 640-644.
[3]	CAO Weiping, ZHANG Shichao, NI Xia, XIE Bing, WANG Xinzhi, XING Mengtao. Research Progress in Liver Injury Caused by Drugs Commonly Used during Pregnancy [J]. Chinese Journal of Pharmacovigilance, 2025, 22(5): 528-531.
[4]	YANG Xuyun, SUN Yang, TIAN Chunhua, HU Zengyao. A National Pharmacovigilance Management System in a New Era [J]. Chinese Journal of Pharmacovigilance, 2025, 22(3): 276-281.
[5]	LI Wenlong, JIA Juanjuan, HUANG Haiwei, YAO Jing, ZHANG Chunqing, WANG Yan, ZHANG Hui. Developments and Prospects of Radiopharmaceuticals in China [J]. Chinese Journal of Pharmacovigilance, 2025, 22(1): 37-42.
[6]	YANG Yuxi, PEI Yusheng, LIU Tao, GAO Hua, CAI Tong. Current situation and reflection on limulus amebocyte lysate and recombinant reagents for testing [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 847-851.
[7]	LI Fang, LONG Xiuying, BAI Na, WEI Jingxia. One case of severe systemic rash caused by atorvastatin calcium tablets [J]. Chinese Journal of Pharmacovigilance, 2024, 21(8): 939-942.
[8]	HJELMSTRÖM Peter, BOWRING Geoffrey, YUE Qun-Ying, NORÉN G. Niklas. Methods for signal management using the global safety database VigiBase [J]. Chinese Journal of Pharmacovigilance, 2024, 21(7): 836-840.
[9]	QIU Jinghui, ZHOU Huziwei, CAO Ying, LI Wenpeng, WANG Shengfeng. Research progress on the influencing factors and intervention measures of opioid requirements [J]. Chinese Journal of Pharmacovigilance, 2024, 21(5): 524-528.
[10]	LIU Jie, ZHANG Jianmin, ZHANG Xiaomeng, LIU Fang, SONG Yuan, ZHONG Xuli. Management of risks to pediatric medications based on drug instructions of Chinese patent medicines in a hospital [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 422-427.
[11]	ZHOU Yue, LIU Shuo, SONG Haibo. Roles of licensed pharmacists in drug classification management [J]. Chinese Journal of Pharmacovigilance, 2024, 21(4): 428-434.
[12]	MA Meiying, ZHAO Xiaopei, ZHANG Mengyao, HU Yilin. Drug traceability coding system in China [J]. Chinese Journal of Pharmacovigilance, 2024, 21(2): 167-172.
[13]	SONG Fuyu, CAO Yi. Establishment of Key Performance Indicators for Drug Inspection [J]. Chinese Journal of Pharmacovigilance, 2024, 21(12): 1411-1414.
[14]	LIU Xin, WANG Guojun. Pharmacological Care of Hypertension Due to Glucocorticoid Drugs [J]. Chinese Journal of Pharmacovigilance, 2024, 21(11): 1303-1305.
[15]	XU Meibao, PEI Yusheng, Liu Yadan, CHEN Chen, DU Ying, LI Wenlong, LIU Tao, CAI Tong. Comparative study of bacterial endotoxin capability verification project at China and abroad [J]. Chinese Journal of Pharmacovigilance, 2024, 21(10): 1113-1117.

Thingking of the Administration of Standardization Technical Committee of Medical Device

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics